Skip to main content

Table 1 Comparative analysis of the variables before and after treatment, independent of genotype

From: Positive association of the hepatic lipase gene polymorphism c.514C > T with estrogen replacement therapy response

Groups

N

Mean (mg/dL)

Standard deviation

t

p

TotalChol

58

210.31

45.47

0.14

0.89

TotalChol2

58

209.41

43.19

  

HDL-C

58

58.95

13.45

0.94

0.35

HDL-C2

58

57.76

14.44

  

LDL-C

58

120.052

38.71

-0.83

0.41

LDL-C2

58

125.52

38.08

  

TG

58

138.07

65.40

2.16

0.03

TG2

58

122.07

66.50

  
  1. TotalChol: total pre-treatment cholesterol; HDL-C: pre-treatment high-density lipoprotein cholesterol; LDL-C: pre-treatment low-density lipoprotein cholesterol; TG: pre-treatment triglycerides; TotalChol2: total post-treatment cholesterol; HDL-C2: post-treatment high-density lipoprotein cholesterol; LDL-C2: post-treatment low-density lipoprotein cholesterol; TG2: post-treatment triglycerides.